1. Flexible-dose oral paliperidone ER in non-acute schizophrenia previously unsuccessfully treated with oral risperidone. (December 2014) Authors: Naber, Dieter; Peuskens, Joseph; Millet, Bruno; Cavallaro, Roberto; Ivanov, Mikhail V; Franco, Manuel A; Doulgeraki, Georgia; Lahaye, Marjolein; Schreiner, Andreas Journal: Clinical practice Issue: Volume 11:Number 6(2014) Page Start: 573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O30 Closure of perianal fistula in patients receiving ustekinumab in the SEAVUE and STARDUST trials. (19th June 2022) Authors: Laurent, Peyrin-Biroulet; Panaccione, Remo; Gasink, Christopher; Hoops, Timothy; Izanec, James L; Ma, Tony; Nazar, Maciej; Bravata, Ivana; Lahaye, Marjolein; Irving, Peter M; Loftus, Edward; Danese, Silvio; Sands, Bruce Journal: Gut Issue: Volume 71(2022)Supplement 1 Page Start: A17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Paliperidone extended-release in patients with non-acute schizophrenia previously unsuccessfully treated with other oral antipsychotics. (April 2014) Authors: Schreiner, Andreas; Lahaye, Marjolein; Peuskens, Joseph; Naber, Dieter; Dilbaz, Nesrin; Millet, Bruno; Franco, Manuel A; Rancans, Elmars; Turczynski, Jacek; Smeraldi, Enrico; Lara, Elsa; Neznanov, Nikolaj G Journal: Expert opinion on pharmacotherapy Issue: Volume 15:Number 5(2014) Page Start: 593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Relationship between clinical outcomes measures and personal and social performance functioning in a prospective, interventional study in schizophrenia. Issue 2 (23rd December 2020) Authors: Vauth, Roland; Carpiniello, Bernardo; Turczyński, Jacek; Ivanov, Mikhail; Cherubin, Pierre; Lahaye, Marjolein; Schreiner, Andreas Journal: International journal of methods in psychiatric research Issue: Volume 30:Issue 2(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Retreatment and prolonged therapy with subcutaneous bortezomib in patients with relapsed multiple myeloma: A randomized, controlled, phase III study. (30th October 2017) Authors: Terpos, Evangelos; Gobbi, Marco; Potamianou, Anna; Lahaye, Marjolein; Couturier, Catherine; Cavo, Michele Journal: European journal of haematology Issue: Volume 100:Number 1(2018) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. S902 Intestinal Ultrasound Response and Transmural Remission After 48 Weeks of Treatment With Ustekinumab in Crohn's Disease: STARDUST Trial Substudy Results by Line of Treatment and by Location. (October 2021) Authors: Kucharzik, Torsten; Wilkens, Rune; D'Agostino, Maria Antonietta; Maconi, Giovanni; Le Bars, Manuela; Lahaye, Marjolein; Bravatà, Ivana; Nazar, Maciej; Ni, Lioudmila; Ercole, Elena; Allocca, Mariangela; Machkova, Nadezda; de Voogd, Floris E.; Palmela, Carolina; Vaughan, Rose; Maaser, Christian Journal: American journal of gastroenterology Issue: Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1 Page Start: S426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial. (April 2022) Authors: Danese, Silvio; Vermeire, Severine; D'Haens, Geert; Panés, Julian; Dignass, Axel; Magro, Fernando; Nazar, Maciej; Le Bars, Manuela; Lahaye, Marjolein; Ni, Lioudmila; Bravata, Ivana; Lavie, Frederic; Daperno, Marco; Lukáš, Milan; Armuzzi, Alessandro; Löwenberg, Mark; Gaya, Daniel R; Peyrin-Biroule... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 4(2022) Page Start: 294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Treatment response and tolerability with once-monthly paliperidone palmitate initiated shortly after hospital admission in patients with schizophrenia. (15th November 2018) Authors: Hargarter, Ludger; Lahaye, Marjolein; Cherubin, Pierre; Lambert, Martin; Swarz, Marnina; Joldygulov, Gali; Vischia, Flavio; Chomskaya, Veronica; Bozikas, Vasilis P.; Tsapakis, Eva-Maria; Schreiner, Andreas Journal: World journal of biological psychiatry Issue: Volume 19(2018)Supplement 3 Page Start: S147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Treatment response, safety, and tolerability of paliperidone extended release treatment in patients recently diagnosed with schizophrenia. (August 2015) Authors: Helldin, Lars; Peuskens, Joseph; Vauth, Roland; Sacchetti, Emilio; bij de Weg, Haye; Herken, Hasan; Lahaye, Marjolein; Schreiner, Andreas Journal: Therapeutic advances in psychopharmacology Issue: Volume 5:Number 4(2015:Aug.) Page Start: 194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗